|
1
|
Di Nicola V: Degenerative osteoarthritis a
reversible chronic disease. Regen Ther. 15:149–160. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hunter DJ and Bierma-Zeinstra S:
Osteoarthritis. Lancet. 393:1745–1759. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Blasioli DJ and Kaplan DL: The roles of
catabolic factors in the development of osteoarthritis. Tissue Eng
Part B Rev. 20:355–363. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Guilak F, Nims RJ, Dicks A, Wu CL and
Meulenbelt I: Osteoarthritis as a disease of the cartilage
pericellular matrix. Matrix Biol. 71-72:40–50. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zeng L, Rong XF, Li RH and Wu XY: Icariin
inhibits MMP-1, MMP-3 and MMP-13 expression through MAPK pathways
in IL-1β-stimulated SW1353 chondrosarcoma cells. Mol Med Rep.
15:2853–2858. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Liu-Bryan R and Terkeltaub R: Emerging
regulators of the inflammatory process in osteoarthritis. Nat Rev
Rheumatol. 11:35–44. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Matejova JP, Spakova T, Harvanova D, Lacko
M, Filip V, Sepitka R, Mitro I and Rosocha J: A Preliminary Study
of Combined Detection of COMP, TIMP-1, and MMP-3 in Synovial Fluid:
Potential Indicators of Osteoarthritis Progression. Cartilage: Aug
4, 2020 (Epub ahead of print).
|
|
8
|
Murphy G, Knäuper V, Atkinson S, Butler G,
English W, Hutton M, Stracke J and Clark I: Matrix
metalloproteinases in arthritic disease. Arthritis Res. 4 (Suppl
3):S39–S49. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Burrage PS, Mix KS and Brinckerhoff CE:
Matrix metalloproteinases: Role in arthritis. Front Biosci.
11:529–543. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Majumdar MK, Askew R, Schelling S, Stedman
N, Blanchet T, Hopkins B, Morris EA and Glasson SS: Double-knockout
of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal
animals and prevents the progression of osteoarthritis. Arthritis
Rheum. 56:3670–3674. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dancevic CM and McCulloch DR: Current and
emerging therapeutic strategies for preventing inflammation and
aggrecanase-mediated cartilage destruction in arthritis. Arthritis
Res Ther. 16:429–440. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang Z, Huang C, Jiang Q, Zheng Y, Liu Y,
Liu S, Chen Y, Mei Y, Ding C, Chen M, et al: Guidelines for the
diagnosis and treatment of osteoarthritis in China (2019 edition).
Ann Transl Med. 8:1213. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Latourte A, Kloppenburg M and Richette P:
Emerging pharmaceutical therapies for osteoarthritis. Nat Rev
Rheumatol. 16:673–688. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li Z, Meng D, Li G, Xu J, Tian K and Li Y:
Celecoxib Combined with Diacerein Effectively Alleviates
Osteoarthritis in Rats via Regulating JNK and p38MAPK Signaling
Pathways. Inflammation. 38:1563–1572. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Konijnenbelt-Peters J, van der Heijden C,
Ekhart C, Bos J, Bruhn J and Kramers C: Metamizole (Dipyrone) as an
Alternative Agent in Postoperative Analgesia in Patients with
Contraindications for Nonsteroidal Anti-Inflammatory Drugs. Pain
Pract. 17:402–408. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pharmacopoeia Committee of the Ministry of
Health of the People's Republic of China: Jian gu zhu she ye
(Jian-gu injection). In: Prescription preparation of Chinese
Medicine. Vol 14. Pharmacopoeia Committee of the Ministry of Health
of the People's Republic of China, pp59-60, 1997 (In Chinese).
|
|
17
|
Ma YH, Sun Q, Yang L, Zhang J and Zhai WT:
Effect of Jiangu injection by shoulder injection combined with
arthroscopic subacromial space decompression on shoulder function
recovery in patients with subacromial impingement syndrome. Mod J
Integr Tradi Chin West Med. 27:2415–2418. 2018.(In Chinese).
|
|
18
|
Chen Z, Hao LD and Zhong W: Clinical
efficacy of pain spot injection with Jiangu injection in acute
lumbar sprain. J Guandong Med Coll. 34:295–297. 2016.(In
Chinese).
|
|
19
|
Wang HQ, Huang YR and Qin XL: Treatment of
40 cases of knee osteoarthritis with acupoint injection of Jiangu
injection. J Guangxi Trad Chin Med Univ. 14:23–24. 2011.(In
Chinese).
|
|
20
|
Chen Y, Yan X, Lu F, Jiang X, Friesen JB,
Pauli GF, Chen SN and Li DP: Preparation of flavone di-C-glycoside
isomers from Jian-Gu injection (Premna fulva Craib.) using
recycling counter-current chromatography. J Chromatogr A.
1599:180–186. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xue Y, Liu Y, Xie Y, Cong C, Wang G, An L,
Teng Y, Chen M and Zhang L: Antioxidant activity and mechanism of
dihydrochalcone C-glycosides: Effects of C-glycosylation and
hydroxyl groups. Phytochemistry. 179(112393)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen GL, Fan MX, Wu JL, Li N and Guo MQ:
Antioxidant and anti-inflammatory properties of flavonoids from
lotus plumule. Food Chem. 277:706–712. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xiao J, Capanoglu E, Jassbi AR and Miron
A: Advance on the Flavonoid C-glycosides and Health Benefits. Crit
Rev Food Sci Nutr. 56 (Suppl 1):S29–S45. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Khan MA, Khurana N, Ahmed RS, Umar S, Md
G, Sarwar AH, Alam Q, Kamal MA and Ashraf GM: Chemokines: A
Potential Therapeutic Target to Suppress Autoimmune Arthritis. Curr
Pharm Des. 25:2937–2946. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Garcia EF, de Oliveira MA, Candido LCM,
Coelho FM, Costa VV, Queiroz-Junior CM, Boff D, Amaral FA, de Souza
DG, Teixeira MM, et al: Effect of the Hydroethanolic Extract from
Echinodorus grandiflorus Leaves and a Fraction Enriched in
Flavone-C-Glycosides on Antigen-Induced Arthritis in Mice. Planta
Med. 82:407–413. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Keshet Y and Seger R: The MAP kinase
signaling cascades: a system of hundreds of components regulates a
diverse array of physiological functions. Methods Mol Biol.
661:3–38. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Thalhamer T, McGrath MA and Harnett MM:
MAPKs and their relevance to arthritis and inflammation.
Rheumatology (Oxford). 47:409–414. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang H, Shan XB and Qiao YJ, Wang H, Shan
XB and Qiao YJ: PDK2 promotes chondrogenic differentiation of
mesenchymal stem cells by upregulation of Sox6 and activation of
JNK/MAPK/ERK pathway. Braz J Med Biol Res. 50(e5988)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sun HY, Hu KZ and Yin ZS: Inhibition of
the p38-MAPK signaling pathway suppresses the apoptosis and
expression of proinflammatory cytokines in human osteoarthritis
chondrocytes. Cytokine. 90:135–143. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Feng Z, Zheng W, Li X, Lin J, Xie C, Li H,
Cheng L, Wu A and Ni W: Cryptotanshinone protects against
IL-1β-induced inflammation in human osteoarthritis chondrocytes and
ameliorates the progression of osteoarthritis in mice. Int
Immunopharmacol. 50:161–167. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
Structure, function, and biochemistry. Circ Res. 92:827–839.
2003.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sharma S, Vazquez-Portalatin N, Calve S
and Panitch A: Biomimetic molecules lower catabolic expression and
prevent chondroitin sulfate degradation in an osteoarthritic ex
vivo model. ACS Biomater Sci Eng. 2:241–250. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yao M, Wang X, Zhao Y, Wang X and Gao F:
Expression of MMPs is dependent on the activity of
mitogen-activated protein kinase in chondrosarcoma. Mol Med Rep.
15:915–921. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kühn K, Shikhman AR and Lotz M: Role of
nitric oxide, reactive oxygen species, and p38 MAP kinase in the
regulation of human chondrocyte apoptosis. J Cell Physiol.
197:379–387. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Joos H, Albrecht W, Laufer S and Brenner
RE: Influence of p38MAPK inhibition on IL-1beta-stimulated human
chondrocytes: A microarray approach. Int J Mol Med. 23:685–693.
2009.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Rahmati M, Nalesso G, Mobasheri A and
Mozafari M: Aging and osteoarthritis: Central role of the
extracellular matrix. Ageing Res Rev. 40:20–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Schroeppel JP, Crist JD, Anderson HC and
Wang J: Molecular regulation of articular chondrocyte function and
its significance in osteoarthritis. Histol Histopathol. 26:377–394.
2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Alexopoulos LG, Youn I, Bonaldo P and
Guilak F: Developmental and osteoarthritic changes in
Col6a1-knockout mice: Biomechanics of type VI collagen in the
cartilage pericellular matrix. Arthritis Rheum. 60:771–779.
2009.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Joos H, Albrecht W, Laufer S and Brenner
RE: Differential effects of p38MAP kinase inhibitors on the
expression of inflammation-associated genes in primary,
interleukin-1β-stimulated human chondrocytes. Br J Pharmacol.
160:1252–1262. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Robinson WH, Lepus CM, Wang Q, Raghu H,
Mao R, Lindstrom TM and Sokolove J: Low-grade inflammation as a key
mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol.
12:580–592. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Woo JH, Lee JH, Kim H, Park SJ, Joe EH and
Jou I: Control of Inflammatory Responses: A New Paradigm for the
Treatment of Chronic Neuronal Diseases. Exp Neurobiol. 24:95–102.
2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Frizziero A, Bonsangue V, Trevisan M, Ames
PRJ and Masiero S: Foot tendinopathies in rheumatic diseases:
Etiopathogenesis, clinical manifestations and therapeutic options.
Clin Rheumatol. 32:547–555. 2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Rai MF and Sandell LJ: Inflammatory
mediators: Tracing links between obesity and osteoarthritis. Crit
Rev Eukaryot Gene Expr. 21:131–142. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Stampella A, Monteagudo S and Lories R:
Wnt signaling as target for the treatment of osteoarthritis. Best
Pract Res Clin Rheumatol. 31:721–729. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Sun K, Luo J, Guo J, Yao X, Jing X and Guo
F: The PI3K/AKT/mTOR signaling pathway in osteoarthritis: A
narrative review. Osteoarthritis Cartilage. 28:400–409.
2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chowdhury TT, Salter DM, Bader DL and Lee
DA: Signal transduction pathways involving p38 MAPK, JNK, NFkappaB
and AP-1 influences the response of chondrocytes cultured in
agarose constructs to IL-1β and dynamic compression. Inflamm Res.
57:306–313. 2008.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Masuko-Hongo K, Berenbaum F, Humbert L,
Salvat C, Goldring MB and Thirion S: Up-regulation of microsomal
prostaglandin E synthase 1 in osteoarthritic human cartilage:
Critical roles of the ERK-1/2 and p38 signaling pathways. Arthritis
Rheum. 50:2829–2838. 2004.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gebauer M, Saas J, Sohler F, Haag J, Söder
S, Pieper M, Bartnik E, Beninga J, Zimmer R and Aigner T:
Comparison of the chondrosarcoma cell line SW1353 with primary
human adult articular chondrocytes with regard to their gene
expression profile and reactivity to IL-1β. Osteoarthritis
Cartilage. 13:697–708. 2005.PubMed/NCBI View Article : Google Scholar
|
